Molecular control of boundary cap stem cell function

Lead Research Organisation: University College London
Department Name: Institute of Ophthalmology

Abstract

We wish to answer fundamental biological questions that will benefit future research into nervous system regeneration by studying a type of neural stem cells known as boundary cap stem cells. These embryonic cells reside in clusters on the borders of the spinal cord and brainstem, where nerves exit and enter to connect to the rest of the body. These clusters, the boundary caps, are thought to be important for the correct development of the nervous system in mammals. In addition, they have the potential to act as stem cells that could be used for nervous system repair and regeneration. For these reasons, we want to understand how boundary caps are formed, how they function in the embryo to aid nervous system development, and how they eventually become nerve cells and support cells to in the adult nervous system. To achieve these goals, we will explore the function of three types of molecules that were previously shown to regulate the behaviour of neurons and blood stem cells and are targetable by clinical drug therapies.

Technical Summary

The vertebrate nervous system is comprised of the central nervous system (CNS), including the brain and spinal cord, and the peripheral nervous system (PNS), containing the autonomic and sensory nerves. Boundary caps (BC) are stem cell clusters on the surface of the embryonic brainstem and spinal cord that guard the interface between the CNS and PNS during embryogenesis by preventing cell body mixing between both compartments, whilst creating a permissive environment for axons to cross between them. After birth, BC stems cells contribute to PNS formation by differentiating into peripheral glia and sensory neurons. The absence of BCs in adults likely contributes to the failure of axons to regenerate across the PNS/CNS border, and the identification of the molecules and mechanisms that determine the fate of boundary caps will therefore fundamentally advance our understanding of PNS development. It will also open up new avenues for research into nervous system regeneration. Our pilot data suggest that the cell surface protein neuropilin 1 (NRP1) is expressed by BC stem cells in vivo and in vitro, and that NRP1 is an important regulator of BC formation, BC differentiation and sensory axon organisation. NRP1 is a well-established receptor for axon guidance molecules of the class 3 semaphorin family, but it also serves as a receptor for the vascular endothelial growth factor termed VEGF164. Spurred by these promising observations, we propose to define the precise role of NRP1 and its ligands in BC development, maintenance and differentiation using a combination of genetic analyses and BC stem cell cultures.

Planned Impact

This main impact of this work will be a significant advancement of our knowledge of the mechanisms that control neural stem cell maintenance and differentiation in vitro and in vivo. This work should be of interest to clinician-scientists involved in developing novel therapeutics for patients with neurodegenerative disorders and/or neurological injury. In the long term, this work will likely be of interest to the commercial sector involved in stem cell therapies/regenerative medicine or developing VEGF therapies and interested in licensing their products for novel purposes. We aim to disseminate our findings to the commercial sector and to clinician specialists in the following ways. Firstly, the project investigator and co-investigator will present the work at national, European and international neuroscience conferences that are attended by both scientists and clinicians. Secondly, the project investigator will explore the potential of clinical application of our research by establishing relevant collaborations. Thirdly, should the project reveal novel signalling pathways that could be targeted in therapies, the project investigator will obtain advice how to protect and commercialise IPR arising from this project. Finally, we will publish our work in open-access journals and disseminate our findings to the public via the media and through teaching in schools and Universities.

Publications

10 25 50
 
Description We have discovered that a type of immune cell called macrophage can stimulate the repair of injured nerves in the leg of mice, because they release a vascular growth factor known as VEGF.

We have also observed that a cell type in the developing mammal called neural crest contributes to jaw growth by stimulating blood vessel growth and to the organisation of nerves at the boundary of the developing peripheral and central nervous system.

We have discovered a molecular mechanism that allows neural crest cells to help establish the innervation of the adrenal medulla.

We have identified a role for boundary cap cells in organising the spinal cord boundaries.
Exploitation Route Others may wish to use VEGF or VEGF-induced blood vessel growth as a therapeutic agent early on after nerve injury to promote repair or in craniofacial disease.
Sectors Pharmaceuticals and Medical Biotechnology

 
Description There are a number of beneficiaries of this work: 1. Our findings are of broad interest to academics working in the fields of regenerative medicine and may be used by researchers in these and other fields to drive their work forward. 2. Our findings are of interest to patients and the lay public and may be used to generate greater understanding of normal development and tissue repair. 3. In the long run, our findings may inform research in the commercial sector to aid in development of novel or more effective therapeutics and tissue engineering strategies for patients with neurochristopathies, neurodegenerative disorders or neurological injuries. This impact has not yet materialised.
First Year Of Impact 2014
Sector Education,Healthcare
Impact Types Societal

 
Description EMBO Fellowship
Amount £29,484 (GBP)
Organisation European Molecular Biology Organisation 
Sector Charity/Non Profit
Country Germany
Start 10/2015 
End 09/2017
 
Description Rosetrees project grant
Amount £8,321 (GBP)
Funding ID A533 
Organisation Rosetrees Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 05/2014 
End 08/2014
 
Description Neural crest cell VEGF in jaw development 
Organisation SA Pathology
Department Department of Immunology
Country Australia 
Sector Public 
PI Contribution We have established a collaboration with Dr Q Schwarz in Adelaide, Australia, on the role of neural crest cells in vascular development in the jaw and mandible growth. My team has contributed ideas and materials as well as some data to this collaboration, and we have written a joint manuscript.
Collaborator Contribution Our collaborators have analysed the sample we sent and performed additional experiments independently of us. The made the figures for the manuscript and they have co-written the manuscript.
Impact A manuscript is under peer-review. The postdoc has presented the work at a conference.
Start Year 2011
 
Description Neurovascular co-patterning in the enteric nervous system 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution We established a collaboration with Dr A Bruns at the UCL Institute of Ophthalmology on neurovascular development in the gut. An undergraduate working in my lab for 6 months on funding provided the grant and the PI contributed ideas, data and research materials to Dr Burn's group. We contributed to the writing of the manuscript. The work was published.
Collaborator Contribution Our collaborators provided ideas and have analysed the samples we sent and performed additional experiments independently of us. They wrote the bulk of the manuscript.
Impact An open access manuscript was published.
Start Year 2012
 
Description Role of VEGF in peripheral nerve regeneration 
Organisation Medical Research Council (MRC)
Country United Kingdom 
Sector Public 
PI Contribution Collaboration established with the MRC Laboratories for Molecular Cell Biology (LMCB) at UCL to complete a project on the role of VEGF in promoting the regeneration of severed peripheral nerves.
Collaborator Contribution We have generated and supplied a new transgenic mouse model to study the role of myeloid-dervied VEGF in the repair of sciatic nerve injury by transection. We have operated a large number of mice for this project and helped with the analysis and interpretation of the results. We contributed to the writing of a manuscript, which has been submitted to and is now in revision for Cell.
Impact A manuscript has been submitted to and is now in revision for Cell.
Start Year 2012